Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors

Expert Review of Anticancer Therapy
J RothbarthC J H van de Velde

Abstract

Isolated hepatic perfusion (IHP) involves a method of complete vascular isolation of the liver to enable treatment of liver tumors with high drug doses without systemic toxicity. Recent clinical studies have mainly employed IHP with melphalan with or without tumor necrosis factor-alpha and mild hyperthermia. The results of these studies demonstrate that high response and survival rates can be achieved with IHP. The current status, recent developments and future perspectives of IHP are discussed in this review.

References

Apr 1, 1979·Annals of Surgery·J P Welch, G A Donaldson
Jul 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P RougierD Gallot
Jan 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D LienardF J Lejeune
Aug 1, 1987·World Journal of Surgery·K SchwemmleB Rieck
Jan 1, 1988·Survey of Ophthalmology·K M EganD M Albert
Nov 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E R SigurdsonJ M Daly
Apr 1, 1985·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·J B JorritsmaA W Konings
Jan 1, 1982·British Journal of Cancer·M C JoinerT C Stephens
Jul 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A L VahrmeijerC J van de Velde
Feb 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G G ChabotR Bugat
Apr 1, 1994·Surgical Oncology·L R HafströmT S Scherstén
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T S RavikumarE D'Andrea
May 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y WatanabeK Jungermann
Jan 1, 1996·Cancer Investigation·C P SchröderR F Ozols
Oct 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M EggermontF J Lejeune
Oct 1, 1996·Japanese Journal of Clinical Oncology·A MarinelliC J van de Velde
Dec 1, 1996·British Journal of Cancer·L OrlandiR Silvestrini
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Meta-analysis Group In CancerE Levy
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H R AlexanderS A Rosenberg
Jul 22, 1998·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Y KuY Saitoh
Jul 22, 1998·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·M R de VriesA M Eggermont
Dec 3, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E RaymondE Cvitkovic

❮ Previous
Next ❯

Citations

Jul 26, 2008·Nature Nanotechnology·Dan PeerRobert Langer
Jun 23, 2012·Journal of Innate Immunity·S M MoghimiA C Hunter
Oct 28, 2009·Annals of Surgical Oncology·Pablo Ortega-DeballonBruno Chauffert
Mar 4, 2014·Journal of Visceral Surgery·O FacyP Ortega Deballon
Aug 7, 2009·Cytokine & Growth Factor Reviews·William K Decker, Amar Safdar
Aug 30, 2008·Surgical Oncology Clinics of North America·Cornelis VerhoefAlexander M M Eggermont

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.